NEW YORK, Sept. 3, 2015 /PRNewswire/ -- The following
statement is being issued by Levi & Korsinsky, LLP:
To: All Persons or Entities who purchased Synergetics
USA, Inc. stock prior to
September 2, 2015.
You are hereby notified that Levi & Korsinsky, LLP
has commenced an investigation into the fairness of
the sale of Synergetics USA, Inc. (NASDAQCM: SURG) to Valeant
Pharmaceuticals International, Inc. (NYSE: VRX) for $6.50 in cash per share plus one contingent value
right entitling shareholders to receive up to $1.00 if Synergetics reaches certain specified
sales thresholds. To learn more about the investigation and your
rights, go to:
http://zlk.9nl.com/synergetics-usa-surg
or contact Joseph E. Levi, Esq.
either via email at jlevi@zlk.com or by telephone at (212)
363-7500, toll-free: (877) 363-5972. There is no cost or
obligation to you.
Levi & Korsinsky is a national firm with offices in
New York, New Jersey, Connecticut and Washington D.C. The firm's attorneys have
extensive expertise in prosecuting securities litigation involving
financial fraud, representing investors throughout the nation in
securities lawsuits and have recovered hundreds of millions of
dollars for aggrieved shareholders. For more information,
please feel free to contact any of the attorneys listed below.
Attorney advertising. Prior results do not guarantee similar
outcomes.
Levi & Korsinsky, LLP
Joseph Levi, Esq.
Eduard Korsinsky, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com
Logo -
http://photos.prnewswire.com/prnh/20120409/MM84375LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/shareholder-alert-levi--korsinsky-llp-notifies-shareholders-of-synergetics-usa-inc-of-commencement-of-an-investigation-concerning-the-fairness-of-the-sale-of-the-company-to-valeant-pharmaceuticals-international-inc----surg-300137798.html
SOURCE Levi & Korsinsky, LLP